Skip to main content
JAGX
NASDAQ Life Sciences

1比35反向股票拆分将在Jaguar Health实施，Nasdaq授予摘牌延期

feedReported by Access Newswire
Sentiment info
Neutral
Importance info
8
Price
$0.375
Mkt Cap
$5.049M
52W Low
$0.313
52W High
$15.48
Market data snapshot near publication time

summarizeSummary

Jaguar Health宣布，将于2026年4月30日实施1比35的反向股票拆分，以遵守Nasdaq的1.00美元竞价规则。该公司还获得了Nasdaq直到2026年5月15日的延期，以证明其合规性。这一行动是在2026年4月21日获得股东批准后进行的潜在反向股票拆分，并直接解决了其最近的10-K中强调的Nasdaq摘牌威胁。虽然延期提供了暂时的摘牌缓解，但反向拆分是公司面临财务挑战的重要企业行动，并不解决根本的业务问题。投资者将密切关注公司是否可以在拆分后维持所需的竞价，并观察其财务健康状况的进一步发展。

在该公告发布时，JAGX的交易价格为$0.38，交易所为NASDAQ，所属行业为Life Sciences，市值约为$504.9万。 52周交易区间为$0.31至$15.48。 这则新闻被评估为中性市场情绪，重要性评分为8/10。 来源：Access Newswire。

show_chartPrice Chart

Share this article

Copied!

feed JAGX - Latest Insights

JAGX
Apr 27, 2026, 9:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Jaguar Health Announces 1-for-35 Reverse Stock Split to Meet Nasdaq Listing Requirements
Sentiment: Negative
View Wiseek Article
JAGX
Apr 27, 2026, 9:00 AM EDT
Source: Access Newswire
Importance Score:
8
1-for-35 Reverse Stock Split Set for Jaguar Health as Nasdaq Grants Delisting Extension
Sentiment: Neutral
View Wiseek Article
JAGX
Apr 21, 2026, 8:22 AM EDT
Filing Type: PRE 14A
Importance Score:
10
Jaguar Health Seeks Shareholder Approval for Highly Dilutive $42.4M Financing to Address Capital Needs
Sentiment: Negative
View Wiseek Article
JAGX
Apr 21, 2026, 7:35 AM EDT
Filing Type: 8-K
Importance Score:
9
Stockholders Approve Massive Share Increase, Two Reverse Splits, and $10.8M Debt Conversion
Sentiment: Negative
View Wiseek Article
JAGX
Apr 13, 2026, 8:30 AM EDT
Source: Access Newswire
Importance Score:
7
Jaguar Health to Leverage AI, Pursue FDA Breakthrough Status for Crofelemer in Rare Disease
Sentiment: Positive
View Wiseek Article
JAGX
Apr 09, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
9
Jaguar Health Believes It Has Regained Nasdaq Stockholders' Equity Compliance, Averting Delisting Threat
Sentiment: Positive
View Wiseek Article
JAGX
Apr 08, 2026, 8:30 AM EDT
Source: Access Newswire
Importance Score:
7
Jaguar Health Completes Pivotal Trial for Canine Diarrhea Drug Crofelemer, Eyes Full FDA Approval
Sentiment: Positive
View Wiseek Article
JAGX
Apr 07, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
9
Jaguar Health Reports Deepening Losses and Nasdaq Delisting Threat Amidst 2025 Financials
Sentiment: Negative
View Wiseek Article
JAGX
Apr 07, 2026, 6:10 AM EDT
Filing Type: 10-K
Importance Score:
9
Jaguar Health Faces Imminent Nasdaq Delisting, Warns of Going Concern Amidst Massive Potential Dilution
Sentiment: Negative
View Wiseek Article
JAGX
Mar 24, 2026, 5:06 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Jaguar Health Seeks Shareholder Approval for Massive Dilution, Two Extreme Reverse Stock Splits
Sentiment: Negative
View Wiseek Article